About this trial
Acute extradural hematoma (EDH) is a potentially life-threatening neurosurgical emergency in children, commonly resulting from traumatic head injury. Early diagnosis and timely surgical intervention are critical factors influencing neurological recovery and overall outcome. Despite advances in neuroimaging and surgical techniques, the clinical presentation, management strategies, and outcomes of pediatric EDH remain variable
Eligibility criteria
Qualifiers
Pediatric patients (<18 years of age).
Patients with traumatic extradural (epidural) hematoma.
Patients who underwent surgical evacuation of the extradural hematoma.
Disqualifiers
Patients with coagulopathy.
Patients with autoimmune disorders.
Patients with a previous operation for extradural hematoma.
Patients with associated intracranial hematomas (e.g., subdural hematoma, subarachnoid hemorrhage, or brain contusion).
Trial design
Treatments tested in this trial
- evacuation of hematoma